COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy

Nat Commun. 2026 May 30;17(1):7026. doi: 10.1038/s41467-026-73455-9.

Abstract

Primary mitochondrial diseases (PMDs) affect approximately 1 in 4300 individuals and cause early-onset neuromuscular and multisystem dysfunction with reduced lifespan. They result from pathogenic variants in mitochondrial or nuclear DNA that impair oxidative phosphorylation. Cytochrome c oxidase (COX; complex IV) deficiency is a well-established cause of PMD, leading to a broad spectrum of phenotypes. COXFA4 (cytochrome c oxidase subunit FA4), formerly NDUFA4, is a nuclear-encoded COX subunit, but its role in disease remains poorly defined. We report the largest genetically confirmed cohort of COXFA4-related PMD to date, comprising 13 individuals from 12 families with biallelic pathogenic COXFA4 variants. All present with Leigh-like encephalopathy and complete loss of COXFA4 protein; however, patient-derived fibroblasts retain residual COX activity, with upregulation of COXFA4L2 (cytochrome c oxidase subunit FA4-like 2), a poorly characterised paralog. Here, we show that COXFA4 is a late-stage COX assembly subunit and identify a paralog-mediated compensatory mechanism with translational potential.

MeSH terms

  • Electron Transport Complex IV* / genetics
  • Electron Transport Complex IV* / metabolism
  • Female
  • Fibroblasts / metabolism
  • Humans
  • Leigh Disease* / genetics
  • Leigh Disease* / metabolism
  • Male
  • Mitochondria / metabolism
  • Mitochondrial Diseases / genetics
  • Mutation
  • Pedigree
  • Up-Regulation

Substances

  • Electron Transport Complex IV